Introduction After years of anticipation, Myanmar has taken the final step in modernizing its intellectual property landscape. Following the “Grand Opening” of the Trademark Registry in 2023, the Department of Intellectual Property (IPD) officially began accepting Patent and Utility Model applications in late 2024, with full examination procedures rolling out in 2025.

Why This Matters For decades, Myanmar relied on an outdated Registration Act where “patents” were merely declared, not examined. Now, under the Patent Law 2019 (implemented 2024/2025), the country has shifted to a formal “First-to-File” system. Inventions are now subject to substantive examination for novelty, inventive step, and industrial applicability, aligning Myanmar with global standards like the TRIPS agreement.

The “Pharma” Exception Crucially for the pharmaceutical industry, the government has clarified that patent protection for pharmaceutical products will be deferred until January 1, 2033, utilizing a waiver available to Least Developed Countries (LDCs). However, “Mailbox” applications can be filed now to preserve priority dates until the protection period opens.

How ASEAN IPR Helps: The transition from “Declaration of Ownership” to formal “Patents” is complex. ASEAN IPR helps you audit your old portfolio to determine which assets need to be re-filed under the new law. We also manage the specific “Mailbox” filings for pharmaceutical clients, ensuring your priority date is locked in for 2033.